Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.40)
# 994
Out of 4,955 analysts
475
Total ratings
41.18%
Success rate
5.79%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $2.40 | +358.33% | 12 | Aug 21, 2025 | |
| PGEN Precigen | Reiterates: Buy | $8.5 | $3.64 | +133.52% | 13 | Aug 19, 2025 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $5 | $1.32 | +278.79% | 10 | Aug 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $50 → $66 | $50.38 | +31.00% | 9 | Aug 18, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $7.66 | +161.10% | 2 | Aug 18, 2025 | |
| AEMD Aethlon Medical | Reiterates: Neutral | $1.5 | $2.19 | -31.51% | 2 | Aug 14, 2025 | |
| VOR Vor Biopharma | Reiterates: Buy | $3 | $2.17 | +38.25% | 14 | Aug 14, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7 → $3.5 | $3.18 | +10.06% | 17 | Aug 13, 2025 | |
| HUMA Humacyte | Maintains: Buy | $4 → $3 | $1.54 | +94.81% | 2 | Aug 12, 2025 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $73 → $80 | $69.06 | +15.84% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $31 | $10.41 | +197.79% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8.5 | $4.66 | +82.40% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $73.59 | +76.65% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.01 | +593.07% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $17.09 | +104.80% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $90 | $4.25 | +2,017.65% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $17.35 | +78.67% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.11 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.89 | +235.80% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.20 | - | 12 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $23.65 | +69.13% | 6 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.03 | +94.17% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $71.03 | +104.14% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $3.35 | +1,691.04% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $2.24 | +391.07% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.63 | +90.11% | 11 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.10 | +351.44% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.02 | +73.27% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.35 | +1,307.41% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.28 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.56 | +173.44% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.24 | +7,935.71% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.12 | +388.28% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.62 | +2,013.82% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.01 | +191.55% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $35.42 | +69.40% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.08 | +366.43% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.31 | +1,491.85% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.92 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.03 | +56.47% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.79 | +616.85% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.66 | +59.01% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.90 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.83 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.55 | +480.65% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $3.61 | +592.52% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.28 | +119.30% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $4.49 | +2,572.61% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.47 | +385.83% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.36 | +5,492.84% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.00 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $5.29 | +13.42% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.35 | +538.30% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $8.63 | +282.39% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $15.93 | -40.36% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.30 | +1,076,823.08% | 1 | Mar 5, 2020 |
CollPlant Biotechnologies
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.40
Upside: +358.33%
Precigen
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $3.64
Upside: +133.52%
Pyxis Oncology
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.32
Upside: +278.79%
Celcuity
Aug 18, 2025
Maintains: Buy
Price Target: $50 → $66
Current: $50.38
Upside: +31.00%
Actuate Therapeutics
Aug 18, 2025
Reiterates: Buy
Price Target: $20
Current: $7.66
Upside: +161.10%
Aethlon Medical
Aug 14, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $2.19
Upside: -31.51%
Vor Biopharma
Aug 14, 2025
Reiterates: Buy
Price Target: $3
Current: $2.17
Upside: +38.25%
X4 Pharmaceuticals
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $3.18
Upside: +10.06%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.54
Upside: +94.81%
Mirum Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $69.06
Upside: +15.84%
Aug 7, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $10.41
Upside: +197.79%
Aug 6, 2025
Maintains: Buy
Price Target: $9 → $8.5
Current: $4.66
Upside: +82.40%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $73.59
Upside: +76.65%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $17.09
Upside: +104.80%
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $4.25
Upside: +2,017.65%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $17.35
Upside: +78.67%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.11
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.89
Upside: +235.80%
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.20
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $40
Current: $23.65
Upside: +69.13%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.03
Upside: +94.17%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $71.03
Upside: +104.14%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $3.35
Upside: +1,691.04%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.24
Upside: +391.07%
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $2.63
Upside: +90.11%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $3.10
Upside: +351.44%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.02
Upside: +73.27%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.35
Upside: +1,307.41%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.28
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.56
Upside: +173.44%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.24
Upside: +7,935.71%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.12
Upside: +388.28%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.62
Upside: +2,013.82%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $24.01
Upside: +191.55%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $35.42
Upside: +69.40%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.08
Upside: +366.43%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.31
Upside: +1,491.85%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.92
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.03
Upside: +56.47%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.79
Upside: +616.85%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.66
Upside: +59.01%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.90
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.83
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.55
Upside: +480.65%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $3.61
Upside: +592.52%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.28
Upside: +119.30%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $4.49
Upside: +2,572.61%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.47
Upside: +385.83%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.36
Upside: +5,492.84%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.00
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $5.29
Upside: +13.42%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.35
Upside: +538.30%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $8.63
Upside: +282.39%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $15.93
Upside: -40.36%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.30
Upside: +1,076,823.08%